Sandbox 54321
From Proteopedia
(Difference between revisions)
| Line 18: | Line 18: | ||
Lisinopril is a drug used mainly to treat hypertension but also to reduce the risk of long-term damage and death in patients suffering from heart failure. Lisinopril controls blood pressure by inhibiting the angiotensin converting enzyme (ACE). By inhibiting ACE, it inevitably prevents the body from synthesizing angiotensin II. | Lisinopril is a drug used mainly to treat hypertension but also to reduce the risk of long-term damage and death in patients suffering from heart failure. Lisinopril controls blood pressure by inhibiting the angiotensin converting enzyme (ACE). By inhibiting ACE, it inevitably prevents the body from synthesizing angiotensin II. | ||
Without the surplus of angiotensin II being made, the blood pressure in the body lowers due to the increase in the ratio of vasodilating angiotensin I to vasoconstricting angiotensin II (Helen, 2016). | Without the surplus of angiotensin II being made, the blood pressure in the body lowers due to the increase in the ratio of vasodilating angiotensin I to vasoconstricting angiotensin II (Helen, 2016). | ||
| - | There are two mechanisms that inhibit ACE proteins due to the different locations they are in the body. Coded by the same gene, the somatic and testis ACE enzymes are closely similar though display some differences. The testes ACE protein consists of two domains which include their own individual HEXXH zinc binding motif which forms many ligands that catalyze the hydrolysis of many mechanisms. In respect to Lisinopril, the zinc ions are involved with the hydrolysis of angiotensin I where the His-Leu dipeptide residues are cleaved at the C domain which restricts access to the active site. The binding position in the C domains actually control the conversion of angiotensin, therefore when Lisinopril binds to ACE, which becomes distorted and curved. The curved and helical structure is known as tACE. This helical structure is formed via the chloride ions near the active site which begin substrate hydrolysis in the C domain. Lisinopril is known to bind to the individual HEXXH zinc binding motif in the lysine side chain and in addition the extended phenyl group near the active site | + | There are two mechanisms that inhibit ACE proteins due to the different locations they are in the body. Coded by the same gene, the somatic and testis ACE enzymes are closely similar though display some differences. The testes ACE protein consists of two domains which include their own individual HEXXH zinc binding motif which forms many ligands that catalyze the hydrolysis of many mechanisms. In respect to Lisinopril, the zinc ions are involved with the hydrolysis of angiotensin I where the His-Leu dipeptide residues are cleaved at the C domain which restricts access to the active site. The binding position in the C domains actually control the conversion of angiotensin, therefore when Lisinopril binds to ACE, which becomes distorted and curved. The curved and helical structure is known as tACE. This helical structure is formed via the chloride ions near the active site which begin substrate hydrolysis in the C domain. Lisinopril is known to bind to the individual HEXXH zinc binding motif in the lysine side chain and in addition the extended phenyl group near the active site <ref>Natesh, R., Schwager, S.L.U., Sturrock, E.D., Acharya, K. R. (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.Nature 421, 551-554 doi:10.1038/nature01370</ref>. |
</StructureSection> | </StructureSection> | ||
Revision as of 21:49, 16 November 2016
Cite error: Invalid <ref> tag;
refs with no name must have content==Your Heading Here (maybe something like 'Structure')== 0
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119
- ↑ Helen, Allen (2016). Lisinopril: Lisinopril ACE inhibitor. Patient. Retrieved from: http://patient.info/medicine/lisinopril-an-ace-inhibitor-zestril
- ↑ National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119 (accessed Nov. 12, 2016).
- ↑ Bouabdallah, S., Dhia, T. B., & Driss, R. (2014, February 25). Study of a Conformational Equilibrium of Lisinopril by HPLC, NMR, and DFT. Retrieved November 12, 2016, from https://www.hindawi.com/journals/ijac/2014/494719/
- ↑ Natesh, R., Schwager, S.L.U., Sturrock, E.D., Acharya, K. R. (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.Nature 421, 551-554 doi:10.1038/nature01370
